181 related articles for article (PubMed ID: 37448552)
1. Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis.
Testa S; Bui NQ; Ganjoo KN
Cancer Res Commun; 2023 Jul; 3(7):1212-1223. PubMed ID: 37448552
[TBL] [Abstract][Full Text] [Related]
2. Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas).
Sanfilippo R; Jones RL; Blay JY; Le Cesne A; Provenzano S; Antoniou G; Mir O; Fucà G; Fumagalli E; Bertulli R; Stacchiotti S; Brahmi M; Grosso F; Dufresne A; Hindi N; Sbaraglia M; Gronchi A; Collini P; Dei Tos AP; Casali PG
Clin Cancer Res; 2019 Sep; 25(17):5295-5300. PubMed ID: 31217199
[TBL] [Abstract][Full Text] [Related]
3. A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report.
Meredith L; Chao T; Nevler A; Basu Mallick A; Singla RK; McCue PA; Bowne WB; Jiang W
Diagn Pathol; 2023 Apr; 18(1):45. PubMed ID: 37041531
[TBL] [Abstract][Full Text] [Related]
4. Perivascular epithelioid cell tumors (PEComa) of the gynecologic tract.
Bennett JA; Oliva E
Genes Chromosomes Cancer; 2021 Mar; 60(3):168-179. PubMed ID: 33099813
[TBL] [Abstract][Full Text] [Related]
5. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review.
Purwar R; Soni K; Shukla M; Verma A; Kumar T; Pandey M
World J Surg Oncol; 2022 Mar; 20(1):62. PubMed ID: 35232443
[TBL] [Abstract][Full Text] [Related]
6. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
Schmiester M; Dolnik A; Kornak U; Pfitzner B; Hummel M; Treue D; Hartmann A; Agaimy A; Weyerer V; Lekaj A; Brakemeier S; Peters R; Öllinger R; Märdian S; Bullinger L; Striefler JK; Flörcken A
J Pathol Clin Res; 2021 Jan; 7(1):3-9. PubMed ID: 33180365
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor.
Wangsiricharoen S; Ingram DR; Morey RR; Wani K; Lazar AJ; Wang WL
Mod Pathol; 2024 Mar; 37(3):100426. PubMed ID: 38219952
[TBL] [Abstract][Full Text] [Related]
8. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
[TBL] [Abstract][Full Text] [Related]
9. TFE3 Gene Rearrangement in Perivascular Epithelioid Cell Neoplasm (PEComa) of the Genitourinary Tract.
Vannucchi M; Minervini A; Salvi M; Montironi R; Raspollini MR
Clin Genitourin Cancer; 2020 Dec; 18(6):e692-e697. PubMed ID: 32576448
[TBL] [Abstract][Full Text] [Related]
10. Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors.
Maloney N; Giannikou K; Lefferts J; Bridge JA; Linos K
Hum Pathol; 2018 Dec; 82():125-130. PubMed ID: 29626599
[TBL] [Abstract][Full Text] [Related]
11. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features.
Shen Q; Rao Q; Xia QY; Yu B; Shi QL; Zhang RS; Zhou XJ
Virchows Arch; 2014 Nov; 465(5):607-13. PubMed ID: 25239799
[TBL] [Abstract][Full Text] [Related]
12. A distinctive subset of PEComas harbors TFE3 gene fusions.
Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
[TBL] [Abstract][Full Text] [Related]
13. Perivascular epithelioid cell tumor (PEComa) of the urinary bladder associated with Xp11 translocation.
Russell CM; Buethe DD; Dickinson S; Sexton WJ
Ann Clin Lab Sci; 2014; 44(1):91-8. PubMed ID: 24695481
[TBL] [Abstract][Full Text] [Related]
14. Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney.
Caliò A; Brunelli M; Gobbo S; Pedron S; Segala D; Argani P; Martignoni G
Pathology; 2021 Aug; 53(5):579-585. PubMed ID: 33461798
[TBL] [Abstract][Full Text] [Related]
15. Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.
Dickson MA; Schwartz GK; Antonescu CR; Kwiatkowski DJ; Malinowska IA
Int J Cancer; 2013 Apr; 132(7):1711-7. PubMed ID: 22927055
[TBL] [Abstract][Full Text] [Related]
16. NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case series.
See SHC; Olivares S; Kulkarni M; Dhillon SK; Fumero-Velazquez MS; Hagstrom MNE; Gerami P
J Cutan Pathol; 2023 Nov; 50(11):956-962. PubMed ID: 37606377
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements.
Neumann NM; Haffner MC; Argani P; Kao CS; Epstein JI
Am J Surg Pathol; 2021 Feb; 45(2):169-177. PubMed ID: 33002920
[TBL] [Abstract][Full Text] [Related]
18. Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.
Bennett JA; Braga AC; Pinto A; Van de Vijver K; Cornejo K; Pesci A; Zhang L; Morales-Oyarvide V; Kiyokawa T; Zannoni GF; Carlson J; Slavik T; Tornos C; Antonescu CR; Oliva E
Am J Surg Pathol; 2018 Oct; 42(10):1370-1383. PubMed ID: 30001237
[TBL] [Abstract][Full Text] [Related]
19. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
20. Pigmented/melanocytic malignant perivascular epithelioid cell tumor with TFE3-SFPQ(PSF) rearrangement - a challenging diagnosis of PEComa family of tumors.
Szumera-Cieækiewicz A; Kuczkiewicz-Siemion O; Seliga K; Grabowska-Kierył M; Tysarowski A; Wągrodzki M; Świtaj T; Prochorec-Sobieszek M; Rutkowski P
Pol J Pathol; 2019; 70(4):317-322. PubMed ID: 32146802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
